3 reasons Emergence companies should apply for the BioInnovation Challenge

Now in its tenth year, the BioInnovation Challenge (BIC) is a pitching competition for early-stage life sciences companies in Atlantic Canada. BIC was created by BioNova to help ease the transition from research to market and recognize the significant commercialization potential of the bioscience sector in Atlantic Canada.

Last year, three Emergence companies were semi-finalists in the BIC: AffinityImmuno and Fieldetect of Prince Edward Island, and Dr. A.K. Gordon of Nova Scotia. This year’s finalists will present at BioPort 2020 in November.

Here are three reasons you should consider applying:

1. Access to funding
The winner of the pitch competition will be awarded $25,000 in funding to help develop their business and a $30,000 advisory services package. Since its inception in 2011, BIC has provided more than $300K in grand prize package value to accelerate start-ups.

2. Pitch training and business development
BIC participants receive pitching and business training to help position their company for continued growth. BIC also connects finalists with investors, the media and industry influencers. Take advantage of the spotlight and kick-start your success.

3. Applying is easy
Deadline for applications is Friday, August 7, 2020. Email kmannette@bionova.ca to receive a copy of the application.

Emergence is a proud supporter of BIC. For more information on the program, visit their website.

This entry was posted in Clients, News. Bookmark the permalink.